Microbot Medical Sees Unusually Large Options Volume (NASDAQ:MBOT)

Microbot Medical Inc. (NASDAQ:MBOT) was the target of some unusual options trading on Monday. Stock investors acquired 2,704 call options on the company. This is an increase of 122% compared to the typical volume of 1,216 call options.

Microbot Medical Stock Up 4.4%

Microbot Medical stock opened at $2.60 on Wednesday. Microbot Medical has a 52 week low of $0.82 and a 52 week high of $3.38. The company has a market capitalization of $94.58 million, a price-to-earnings ratio of -3.25 and a beta of 1.14. The stock has a 50-day moving average price of $2.40 and a 200 day moving average price of $1.84.

Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings results on Wednesday, May 21st. The biotechnology company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.07. Research analysts anticipate that Microbot Medical will post -0.71 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and issued a $9.00 price target on shares of Microbot Medical in a report on Thursday, April 10th.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in MBOT. Geode Capital Management LLC lifted its holdings in Microbot Medical by 7.9% during the fourth quarter. Geode Capital Management LLC now owns 142,659 shares of the biotechnology company’s stock valued at $160,000 after purchasing an additional 10,442 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Microbot Medical in the first quarter valued at about $42,000. Goldman Sachs Group Inc. purchased a new position in shares of Microbot Medical in the first quarter worth about $57,000. Finally, Renaissance Technologies LLC purchased a new stake in Microbot Medical during the 4th quarter valued at about $118,000. 16.30% of the stock is owned by institutional investors and hedge funds.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.